CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Castle Biosciences Approved for Dual Listing on Nasdaq Texas

Positive
AI Analysis

Summary

Castle Biosciences has received approval for dual listing of its common stock on Nasdaq Texas, a new exchange.

Outcome Details

Approved for dual listing on Nasdaq Texas

Importance:2/10
Sentiment:
0.30
exchange listingnasdaq texasdual listing
Related Companies

Read the original article

Published by PR Newswire Biotech on August 17, 2026 11:00 AM

Read Original